A new study conducted in the United States, considered to be the largest of its kind to date, explored explored the effects of memory and attention issues affecting breast cancer survivors after undergoing chemotherapy treatment. According to study author Michelle Janelsins, assistant professor o surgery, radiation oncology and neuroscience at the University of Rochester Medical Center and the Wilmot Cancer Institute in New York, "a month after chemo ended, 45% of patients reported a significant decline in so-called cognitive abilities", an effect that continued to linger 6 months later where "36% of patients still felt their mental ability had declined."
To read more about this study, click here.
No comments:
Post a Comment